FDA Proposes More Restrictive Expiration Dating For Repackaged Solid Oral Drugs
Executive Summary
FDA has proposed to tighten proposed limits on the use of oral solid drugs from one year to just six months after they're repackaged into unit doses, except under certain circumstances, in line with USP standards on expiration dating.
You may also be interested in...
US FDA Allows Simpler Approach To Expire Dating When Repackaging Drugs Into Unit Doses
The US FDA will not enforce expiration dating requirements for unit-dose repackaging if repackagers follow an alternative approach outlined in final guidance.
FDA Extends Expiration Dating Of Repackaged Drugs To One Year
The agency proposes revising a 1984 guideline that provided a six-month maximum expiration date for nonsterile, unit-dose repackaged drugs without additional stability studies. FDA's draft guidance would harmonize enforcement policies on expiration dating with USP standards.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”